MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字H20234650

December 13, 2023

Drug Information

米拉贝隆缓释片

片剂

25mg

化学药品

December 13, 2023

Company Information

Applicant Company

深圳市坪山新区兰竹东路国家生物医药产业基地万乐药业大厦

Manufacturing Company

深圳国家生物医药产业基地坪山新区兰竹东路万乐药业大厦

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath